Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study

BACKGROUND: We evaluated treatment decisions and outcomes in a cohort of predominately Caucasian patients with EGFR mutation-positive (EGFR Mut+) non-small-cell lung cancer (NSCLC). METHODS: REASON (NCT00997230) was a non-interventional study in German patients with stage IIIB/IV NSCLC. Secondary en...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuette, Wolfgang, Schirmacher, Peter, Eberhardt, Wilfried E. E., Dietel, Manfred, Zirrgiebel, Ute, Muehlenhoff, Lars, Thomas, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799904/
https://www.ncbi.nlm.nih.gov/pubmed/29402243
http://dx.doi.org/10.1186/s12885-018-4032-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799904/
https://www.ncbi.nlm.nih.gov/pubmed/29402243
http://dx.doi.org/10.1186/s12885-018-4032-3

Ejemplares similares